Tag: Novo Nordisk A/S

Jim Cramer says he can’t sell Eli Lilly despite its massive run up. Here’s why

Novo and Lilly are competing to win the GLP-1 pill market as they prepare for Medicare coverage

Weight loss drug maker sinks 25% after new safety data spooks investors

CVS to restore coverage of Zepbound, add Eli Lilly’s obesity pill to drug plans

Signos grows foothold in weight-loss wave fueled by GLP-1s with its AI health data tracking

Eli Lilly says next-generation weight loss drug clears crucial obesity trial

White House adds generic drugs to direct-to-consumer TrumpRx site

Medicare Coverage for GLP-1 Weight Loss Drugs: Cost, Eligibility and What to Know

Hantavirus outbreak isn’t another Covid pandemic – but experts say it’s testing U.S. readiness

Novo Nordisk says high-dose Wegovy helped some patients lose nearly 28% of their weight